Lv61
2640 积分 2021-12-12 加入
Applications of Cell-Based Protein Array Technology to Preclinical Safety Assessment of Biological Products
7小时前
已完结
Acute myeloid leukaemia
15天前
已完结
CD19-CAR T-cell therapy induces deep tissue depletion of B cells
15天前
已完结
CD19 CAR T-Cell Therapy for Autoimmune Hemolytic Anemia
1个月前
已完结
CD19 CAR T-Cell Therapy for Autoimmune Hemolytic Anemia
1个月前
已完结
BCMA-CD19 compound CAR T cells for systemic lupus erythematosus: a phase 1 open-label clinical trial
1个月前
已完结
mRNA Cancer Vaccines: From Pandemic Paradigm to Personalized Oncology Therapeutics
1个月前
已完结
Individualised neoantigen therapy mRNA-4157 (V940) plus pembrolizumab versus pembrolizumab monotherapy in resected melanoma (KEYNOTE-942): a randomised, phase 2b study
1个月前
已完结
Individualised neoantigen therapy mRNA-4157 (V940) plus pembrolizumab versus pembrolizumab monotherapy in resected melanoma (KEYNOTE-942): a randomised, phase 2b study
1个月前
已完结
T-cell Responses to Individualized Neoantigen Therapy mRNA-4157 (V940) Alone or in Combination with Pembrolizumab in the Phase 1 KEYNOTE-603 Study
1个月前
已完结
皖公网安备34019202002308
